Andrew Bellinger

2022

In 2022, Andrew Bellinger earned a total compensation of $3.3M as Chief Scientific Officer and Chief Medical Officer at Verve Therapeutics, which was about the same as previous year.

Compensation breakdown

Non-Equity Incentive Plan$215,280
Option Awards$2,615,650
Salary$476,100
Other$12,468
Total$3,319,498

Bellinger received $2.6M in option awards, accounting for 79% of the total pay in 2022.

Bellinger also received $215.3K in non-equity incentive plan, $476.1K in salary and $12.5K in other compensation.

Rankings

In 2022, Andrew Bellinger's compensation ranked 1,087th out of 5,753 executives tracked by ExecPay. In other words, Bellinger earned more than 81.1% of executives.

ClassificationRankingPercentile
All
1,087
out of 5,753
81st
Division
Manufacturing
517
out of 3,133
84th
Major group
Chemicals And Allied Products
186
out of 1,419
87th
Industry group
Drugs
167
out of 1,320
87th
Industry
Pharmaceutical Preparations
125
out of 966
87th
Source: SEC filing on April 28, 2023.

Bellinger's colleagues

We found two more compensation records of executives who worked with Andrew Bellinger at Verve Therapeutics in 2022.

2022

Sekar Kathiresan

Verve Therapeutics

Chief Executive Officer

2022

Andrew Ashe

Verve Therapeutics

Chief Operating Officer

News

In-depth

You may also like